Related Experiment Videos
Public health value of fixed-dose combinations in hypertension
Luis M Ruilope1, Michel Burnier, Noemi Muszbek
1Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain. ruilope@ad-hocbox.com
Insights
Fixed-dose combinations (FDCs) for hypertension treatment can improve patient adherence and persistence. This approach may enhance efficacy and tolerability, potentially reducing cardiovascular events and healthcare costs.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Reducing blood pressure (BP) in hypertensive individuals is crucial for lowering cardiovascular (CV) event risk.
- Many patients with hypertension are undertreated, failing to achieve target BP goals, leading to significant health and economic burdens.
- Poor patient compliance and persistence are key contributors to suboptimal BP control.
Purpose of the Study:
- To evaluate the potential of fixed-dose combinations (FDCs) in improving patient compliance and persistence for hypertension management.
- To compare the efficacy, tolerability, and cost-effectiveness of FDCs against antihypertensive monotherapies.
Main Methods:
- This study reviews existing literature and clinical evidence on the use of FDCs in hypertension treatment.
- Comparative analysis of FDCs versus monotherapies regarding efficacy, tolerability, and patient adherence metrics.
- Assessment of the potential impact of FDCs on CV event rates and healthcare economics.
Main Results:
- FDCs have demonstrated potential to improve patient compliance and persistence in hypertension therapy.
- FDCs may offer comparable or superior efficacy and tolerability profiles relative to individual antihypertensive drugs.
- The adoption of FDCs could lead to a reduction in CV events and associated non-drug healthcare expenditures.
Conclusions:
- Fixed-dose combinations represent a promising strategy for enhancing hypertension management by improving patient adherence.
- FDCs offer a viable option for achieving better BP control, potentially reducing cardiovascular morbidity and healthcare costs.
- Addressing practical considerations such as copayment, formulary restrictions, and pricing is essential for the successful implementation of FDCs in hypertension treatment.
Abstract:
It is well documented that reducing blood pressure (BP) in hypertensive individuals reduces the risk of cardiovascular (CV) events. Despite this, many patients with hypertension remain untreated or inadequately treated, and fail to reach the recommended BP goals. Suboptimal BP control, whilst arising from multiple causes, is often due to poor patient compliance and/or persistence, and results in a significant health and economic burden on society. The use of fixed-dose combinations (FDCs) for the treatment of hypertension has the potential to increase patient compliance and persistence. When compared with antihypertensive monotherapies, FDCs may also offer equivalent or better efficacy, and the same or improved tolerability. As a result, FDCs have the potential to reduce both the CV event rates and the non-drug healthcare costs associated with hypertension. When FDCs are adopted for the treatment of hypertension, issues relating to copayment, formulary restrictions and therapeutic reference pricing must be addressed.
Related Concept Videos
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dosage Regimen: Individualization
Hypertension IV: Drug Therapy and Lifestyle Modifications
Dosage Regimens: Designs and Approaches